Nrf2activation via Keap1 knockdown or BARD treatment elevates Smad7 proteinlevel through the suppression of Smurf1 expression, and thereby inhibitsSmad2/3 signaling. These events attenuated ECM production and histopathological changes in the kidney of AA-treated mice.